Mistakes to Be Avoided When Preparing a Drug Launch
The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company […]
The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company […]
EU-funded researchers have demonstrated a new type of biomedical sensor featuring embedded intelligence. The sensor measures ion concentrations but the computing principles have far-reaching implications […]
EU-funded researchers have developed a hands-free, voice-controlled system for smart homes to facilitate and improve the day-to-day lives of seniors and the disabled, enabling them […]
EU-funded researchers have developed a hands-free, voice-controlled system for smart homes to facilitate and improve the day-to-day lives of seniors and the disabled, enabling them […]
EU-funded researchers have developed a hands-free, voice-controlled system for smart homes to facilitate and improve the day-to-day lives of seniors and the disabled, enabling them […]
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract […]
Miniscule messenger bubbles floating in all your bodily fluids could hold important insights into many complex diseases from Alzheimer’s to heart disease – if they […]
A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of […]
A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of […]
A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of […]
A wide-reaching EU-funded project is testing new anti-blood clotting treatment in patients who have suffered a brain haemorrhage. Researchers hope to reduce the risk of […]
You can enroll in or renew a 2020 plan November 1 through December 15. You can start by previewing 2020 plans with personalized estimates. Note: […]
A wide-reaching EU-funded clinical trial is testing thrombectomies for severe stroke patients. Researchers hope to show that the treatment – which is only currently available […]
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, […]
Directive2019/1831 – indicative occupational exposure limit values of 24 October 2019 establishing a fifth list of indicative occupational exposure limit values pursuant to Council Directive […]
21/10/2019 – 01:30 Join EU-OSHA in marking the European Week for Safety and Health at Work 2019 Between 21 and 25 October the European Agency […]
<h2 class="heading-medium">Does Value-Based Pay Have A Future?</h2> While just about everyone in healthcare likes the idea of paying for outcomes, there still remains a challenge […]
Shots: The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance- supporting patients with a high risk of AFib. The companies will focus […]
Shots: The approval of expanded indication is based on P-III CAPSTONE-2 study assessing Xofluza (40/80mg) vs oseltamivir (75mg bid for 5days) & PBO in people […]
Shots: The EMA’s CHMP has adopted a positive opinion recommending marketing authorization for Evenity (romosozumab) based on P-III global studies including FRAME- ARCH and BRIDGE […]
Shots: Cipla acquires Venus’ anti-infective products- Elores to robust its presence in Indian critical care space as a part of its agenda to contribute to […]
Before you apply for 2020 Marketplace health insurance starting November 1, there are several things to consider that’ll help you choose the plan that’s right […]
Shots: Pear Therapeutics will solely be responsible for commercialization of its prescription digital therapeutics (PDTs)- reSET and reSET-O- therapies to treat substance use disorder (SUD) […]
Shots: AstraZeneca has selected PetaGene’s PetaSuite software to compress the genomics data sets for its Centre for Genomics Research (CGR)- which investigates genetic causes of […]
Shots: The BLA submission is based on P-I study and the pivotal P-II DESTINY-Breast01 study. The P-II DESTINY-Breast01 study assessing Trastuzumab deruxtecan in 253 patients […]
Shots: The launch of Drizalma Sprinkle expands Sun Pharma’s portfolio of an alternative formulation designed for patients with swallowing difficulties- following its Ezallor Sprinkle (Rosuvastatin) […]
Shots: Blueprint to receive $535M including $25M up front and up to $510M as development- regulatory & commercial milestone for BLU-782 in up to two […]
Shots: The P-III BE VIVID study involves assessing of Bimekizumab vs PBO & Ustekinumab in 570 patients with chronic plaque psoriasis for at least 6mos. […]
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very familiar with — whether it […]
Do you offer simple, fast, and reliable digital interaction to your consumers? Is it possible to convert every customer into a collection opportunity? The answer […]
Open Enrollment for 2020 Marketplace coverage starts November 1, 2019. There are things you can do now to get ready, whether you’re applying for the […]
Any surgical procedure can be risky, especially for older people. To minimise the dangers, EU-funded researchers have developed the world’s first personalised test to assess […]
Any surgical procedure can be risky, especially for older people. To minimise the dangers, EU-funded researchers have developed the world’s first personalised test to assess […]
Any surgical procedure can be risky, especially for older people. To minimise the dangers, EU-funded researchers have developed the world’s first personalised test to assess […]
Using neurons grown from stem cells, EU-funded researchers are revealing more about mutations that lead to autism, schizophrenia and intellectual disability which researchers hope will […]
Using neurons grown from stem cells, EU-funded researchers are revealing more about mutations that lead to autism, schizophrenia and intellectual disability which researchers hope will […]
EU-funded researchers are investigating the causes and consequences of ADHD with the aim of improving the lives of patients and reducing their risk of developing […]
EU-funded researchers are investigating the causes and consequences of ADHD with the aim of improving the lives of patients and reducing their risk of developing […]
This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Despite the important role […]
WHO reports show that more than 3 million people died from alcohol-related illness in 2016, yet low-cost interventions to measure how much people drink can […]
Shots: Goldfinch to be responsible for all WW development & commercialization activities of GFB-024. Takeda to get an option to sub-license rights of GFB-024- prior […]
Shots: The US FDA’s approval is based on P-III DISCOVERY study assessing Descovy (emtricitabine- 200mg and tenofovir alafenamide- 25mg) vs Truvada (emtricitabine- 200mg and tenofovir […]
Shots: The US FDA has approved the self-administration of Fasenra (benralizumab) in a pre-filled- single-use auto-injector- based on P-III GRECO and P-I AMES study The […]
Shots: Microsoft & Silver Cloud collaborate to enhance its online offering with AI and had been working together over the past 18 mos. conducting research […]
You have less than one month until you can enroll in a 2020 Marketplace health insurance plan. Here are important dates to remember and some […]
Shots: Novartis to launch AI innovation lab with Microsoft as its strategic AI and data-science partner to transform the discovery- development & commercialization of medicines […]
Shots: Biocon & Mylan launch the Semglee (insulin glargine solution for injection 100 IU/mL in a 3mL pre-filled pen) as the first Insulin Glargine biosimilar […]
Shots: Air Ambulance Kent Surrey Sussex (AAKSS) will equip all its emergency service helicopters with the Philips RDT Tempus ALS and Philips IntelliSpace Corsium web-based […]
Shots: The P-IV IXORA-R study involves assessing of Taltz vs Tremfya (guselkumab) in 1-027 patients with moderate to severe plaque psoriasis for a total of […]
Shots: The NMPA approval is based on the P-III KEYNOTE-042 study assessing Keytruda as monothx. vs CT in patients with stage III NSCLC who were […]
Shots: The safety & efficacy of Emgality (120mg after an initial loading dose of 240mg) is evaluated in three P-III studies EVOLVE-1- EVOlVE-2 and REGAIN […]
Copyright © 2024 | WordPress Theme by MH Themes